Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in early-stage Parkinson's disease
NL-OMON59619Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in Parkinson's disease (PD), sponsored by Amsterdam University Medical Center. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON59619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59619.